Hollencrest Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Hollencrest Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1K	Hold	50	–	–	﹤0.01%	1022
2026 Q1	$1.32K	Hold	50	–	–	﹤0.01%	1061
2025 Q4	$1.45K	Hold	50	–	–	﹤0.01%	1046
2025 Q3	$1.39K	Hold	50	–	–	﹤0.01%	1019
2025 Q2	$1.22K	Hold	50	–	–	﹤0.01%	1010
2025 Q1	$1.04K	Hold	50	–	–	﹤0.01%	1014
2024 Q4	$1.18K	Hold	50	–	–	﹤0.01%	1051
2024 Q3	$1.28K	Hold	50	–	–	﹤0.01%	990
2024 Q2	$1.17K	Hold	50	–	–	﹤0.01%	975
2024 Q1	$1.44K	Hold	50	–	–	﹤0.01%	939
2023 Q4	$1.64K	Hold	50	–	–	﹤0.01%	913
2023 Q3	$1.39K	Hold	50	–	–	﹤0.01%	955
2023 Q2	$1.71K	Hold	50	–	–	﹤0.01%	981
2023 Q1	$1.5K	Hold	50	–	–	﹤0.01%	985
2022 Q4	$1.41K	Buy	+50	New	+$1.59K	﹤0.01%	982

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Hollencrest Capital Management's ARKG Position: Q2 2026 in Review

Hollencrest Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 50 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Hollencrest Capital Management first reported a position in ARKG in Q4 2022 and has held it in 15 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Hollencrest Capital Management held 50 shares of ARK Genomic Revolution ETF worth $2.1K as of Q2 2026.
Hollencrest Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #1022 holding.
Hollencrest Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 15 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.